Stay updated on Cenobamate Open-Label Extension Study Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.

Latest updates to the Cenobamate Open-Label Extension Study Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check41 days agoChange DetectedThe page has been updated to include new information about Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy and a new revision number, while significant details about previous studies and their protocols have been removed.SummaryDifference19%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check92 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check106 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Cenobamate Open-Label Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.